遗传和获得的糖酶-异盐酸酶缺乏症:临床综述
Tanaz Farzan Danialifar1,2, Bruno P Chumpitazi3,4, Devendra I Mehta5
1Children's Hospital Los Angeles, Los Angeles, California, USA.
Journal of pediatric gastroenterology and nutrition
|February 8, 2024
概括
遗传糖酶-异盐酸酶缺乏症 (GSID) 是一种遗传性疾病,由于SI基因突变影响了糖糖的消化. 证据表明严重程度和晚期发病的频谱,影响诊断和管理.
科学领域:
- 遗传学 是一个遗传学.
- 胃肠病学 胃肠病学
- 生物化学 生物化学
背景情况:
- 遗传糖酶-异酸酶缺乏症 (GSID) 是由SI基因突变引起的,影响了糖糖和粉的消化.
- 历史上被认为在婴儿中很罕见,GSID变体在晚年越来越多地出现,具有类似易怒肠综合征的症状.
- 已识别出GSID严重程度和呈现开始的频谱,需要更新术语.
研究的目的:
- 审查目前对遗传糖酶-异酸酶缺乏症 (GSID) 的理解.
- 讨论GSID的诊断挑战和管理策略.
- 突出需要在GSID中进一步研究的领域.
主要方法:
- 关于遗传糖酶-异酸酶缺乏症 (GSID) 的现有文献的综述.
- 对诊断方法的分析,包括脱糖酶测定和呼吸测试.
- 评估当前的管理方法,包括饮食限制和酶替代疗法.
主要成果:
- SI基因变异可以导致一系列的GSID严重程度和呈现年龄.
- 脱糖酶测试是黄金标准,但非侵入性测试需要验证.
- 饮食修改和圣酶是主要的治疗方法,尽管一些患者需要持续限制粉.
结论:
- GSID是一个比以前想象的更广泛的表现谱的条件.
- 对GSID的最佳诊断和治疗策略需要进一步的研究,特别是在儿科患者群体中.
- 澄清SI异胞突变的流行率和病理生物学对于改善患者护理至关重要.
相关概念视频
Glucose Transporters
22.8K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.8K
Inborn Errors of Metabolism
160
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
160
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Glucose Absorption Into the Small Intestine
31.7K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.7K
Overview of Carbohydrate Metabolism
1.0K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.0K
Oral Hypoglycemic Agents: Sulfonylureas
209
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
209


